GE HealthCare Technologies (GEHC) Net Margin (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Net Margin came in at 10.84% in Q2 2026, up 85.0% on a YoY basis from 5.86% in Q2 2025, and up 35.33% quarter-over-quarter from 8.01% in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Net Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Net Margin for 5 consecutive years, with 10.84% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 85.0% year-over-year to 10.84%; the trailing twelve-month figure through Jun 2026 stood at 9.64% (down 177.0% YoY), and the FY2025 full-year result was 10.1%, down 3.0% from the prior year.
- Net Margin grew to 10.84% in Q2 2026 per GEHC's latest filing, from 8.01% in the prior quarter.
- Across five years, Net Margin topped out at 13.56% in Q4 2024 and bottomed at 4.02% in Q1 2023.
- Historically, Net Margin has averaged 9.48% across 5 years, with a median of 9.34% in 2025.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 494 bps in 2023, then soared 581 bps in 2024.
- Over 5 years, Net Margin stood at 11.22% in 2022, then tumbled by 31 bps to 7.74% in 2023, then surged by 75 bps to 13.56% in 2024, then slipped by 22 bps to 10.57% in 2025, then advanced by 3 bps to 10.84% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 10.84%, 8.01%, and 10.57% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 10.84% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 19.33% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | -24.57% |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -4.66% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -39.59% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -68.58% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 7.55% |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -19.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.84% |
| Mar 31, 2026 | 8.01% |
| Dec 31, 2025 | 10.57% |
| Sep 30, 2025 | 9.02% |
| Jun 30, 2025 | 9.99% |
| Mar 31, 2025 | 12.31% |
| Dec 31, 2024 | 13.56% |
| Sep 30, 2024 | 9.66% |
| Jun 30, 2024 | 8.84% |
| Mar 31, 2024 | 8.04% |
| Dec 31, 2023 | 7.74% |
| Sep 30, 2023 | 7.78% |
| Jun 30, 2023 | 8.68% |
| Mar 31, 2023 | 4.02% |
| Dec 31, 2022 | 11.22% |
| Sep 30, 2022 | 10.64% |
| Jun 30, 2022 | 10.82% |
| Mar 31, 2022 | 8.96% |